The importance of follow-up biopsies of clinically suspicious lymphadenopathy in nodular lymphocyte predominant Hodgkin's lymphoma

Haematologica

Volumn 88, Issue 12, 2003, Pages 1431-1432

  Achten, Ruth ^a   Verhoef, Gregor ^a   De Wolf Peeters, Chris ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Diffuse large B cell lymphoma; Nodular lymphocyte predominant Hodgkin's lymphoma; Progressive transformation of germinal centers

Indexed keywords

ARTICLE; B LYMPHOCYTE; CANCER RECURRENCE; CELL STRUCTURE; CLINICAL ARTICLE; CLINICAL FEATURE; FOLLOW UP; HISTIOCYTE; HISTOLOGY; HODGKIN DISEASE; HUMAN; HYPERPLASIA; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; LYMPH NODE BIOPSY; LYMPHADENOPATHY; LYMPHOCYTE; NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA; PROGNOSIS; TUMOR BIOPSY;

BIOPSY; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HODGKIN DISEASE; HUMANS; LYMPH NODES; LYMPHOMA, LARGE-CELL, DIFFUSE; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; RETROSPECTIVE STUDIES;

EID: 0347993917     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Diehl V, Sextro M, Franklin J, Hansmann ML, Harris N, Jaffe E, et al. Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease. J Clin Oncol 1999;17:776-83.
2. Orlandi E, Lazzarino M, Brusamolino E, Paulli M, Astori C, Magrini U, et al. Nodular lymphocyte predominance Hodgkin's disease: long-term observation reveals a continuous pattern of recurrence. Leuk Lymphoma 1997;26: 359-68.
3. Regula DP Jr, Hoppe RT, Weiss LM. Nodular and diffuse types of lymphocyte predominance Hodgkin's disease. N Engl J Med 1988;318:214-9.
4. Henry-Amar M, Joly F. Late complications after Hodgkin's disease. Ann Oncol 1996; 7 Suppl 4:115-26.
5. Bennett MH, MacLennan KA, Vaughan HG, Vaughan HB. Non-Hodgkin's lymphoma arising in patients treated for Hodgkin's disease in the BNLI: a 20-year experience. British National Lymphoma Investigation. Ann Oncol 1991; 2 Suppl 2:83-92.
6. Henry-Amar M. Second cancer after the treatment for Hodgkin's disease: a report from the International Database on Hodgkin's Disease. Ann Oncol 1992; 3 Suppl 4: 117-28.
7. Swerdlow AJ, Douglas AJ, Vaughan HG, Vaughan HB, MacLennan KA. Risk of second primary cancer after Hodgkin's disease in patients in the British National Lymphoma Investigation: relationships to host factors, histology and stage of Hodgkin's disease, and splenectomy. Br J Cancer 1993;68:1006-11.
8. Sundeen JT, Cossman J, Jaffe ES. Lymphocyte predominant Hodgkin's disease nodular subtype with coexistent "large cell lymphoma". Histological progression or composite malignancy. Am J Surg Pathol 1988;12:599-606.
9. De Jong D, Van Gorp J, Sie-Go D, Van Heerde P. T-cell rich B-cell non-Hodgkin's lymphoma: a progressed form of follicle centre cell lymphoma and lymphocyte predominance Hodgkin's disease. Histopathology 1996;28:15-24.